Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL6473273

CCCC[N+](CCCC)(CCCC)CCCC.c1ncc2nc[nH]c2n1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 3/20 0.36
▸ HRH3 Q9Y5N1 3/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ XDH P47989 1/20 0.33
▸ PAK1 Q13153 1/20 0.33
▸ SLC22A2 O15244 1/20 0.32
▸ EPHX1 P07099 1/20 0.32
▸ CDK1 P06493 2/20 0.31
▸ CCNB1 P14635 2/20 0.31
▸ CCNA2 P20248 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ CCNA1 P78396 1/20 0.31
▸ HRH4 Q9H3N8 2/20 0.31
▸ LATS1 O95835 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Purine SCHEMBL3021752 0.80 KDM4A (0.36) —
Purine SCHEMBL3157 0.80 — —
Purine SCHEMBL2120547 0.80 KDM4A (0.38) XDH
Purine SCHEMBL6438162 0.78 KDM4A (0.37) —
Purine SCHEMBL9603027 0.78 — —
Purine SCHEMBL311318 0.78 KDM4A (0.37) —
Tetrabuthylammonium SCHEMBL6473275 0.76 PAK1 (0.41) SLC22A1HRH3XDHPAK1CDK1
Purine SCHEMBL20520352 0.75 KDM4A (0.39) —
Purine SCHEMBL1827535 0.75 KDM4A (0.35) —
Purine SCHEMBL7787939 0.73 KDM4A (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1535923-A1 Synthesis of acyclic nucleoside derivatives Medivir Aktiebolag (SE) 2005-06-01 — — EP disclosed
EP-1131323-A1 SYNTHESIS OF ACYCLIC NUCLEOSIDE DERIVATIVES Medivir Aktiebolag (SE) 2001-09-12 — — EP disclosed
WO-2000008025-A1 SYNTHESIS OF ACYCLIC NUCLEOSIDE DERIVATIVES MEDIVIR AB (SE) 2000-02-17 — — WO disclosed
Send feedback